Pfizer (NYSE:PFE) reported lower fourth-quarter revenue as demand for its COVID-19 treatments continued to fade, but stronger ...

A South Dakota legislative panel greenlit a bill Tuesday that offers liability protections for doctors and pharmacists who issue or fill off-label prescriptions for antiparasitic and antimalarial ...

GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance coverage disparities.

Pfizer reported fourth-quarter results that beat expectations, offering a steadier earnings picture as the company moves further away from the Covid-driven revenue surge of recent years. While demand ...

A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...

(RTTNews) - Aethlon Medical, Inc. (AEMD) announced that U.S. Patent No. 12,409,260, covering the use of its Hemopurifier for Long COVID treatment, will issue on September 9, 2025. Additionally, ...

Courts have been botching 1905 precedent upholding mandate for vaccine that actually stops transmission since Buck v. Bell, ...

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and... Long COVID patients are frustrated that federal ...

Why some people experience long-lasting physical and mental effects from COVID-19 could be linked to chronic inflammation, according to new research that experts say could help develop new treatments ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

A South Dakota legislative panel greenlit a bill Tuesday that would protect doctors and pharmacists who issue or fill ...